Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

This study is designed to compare efficacy and safety of GQ1005 versus T-DM1 in HER2-positive, unresectable and/or metastatic breast cancer patients previously treated with trastuzumab and taxane.

Participants needed: 228
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: GeneQuantum Healthcare (Suzhou) Co., Ltd.Updated: Jun 29, 2026Locations: 70
Eligibility criteria

Male or female adults ≥ 18 years at the time of voluntary signing of informed co... [+5]

Prior anti-HER2 ADC therapy. [+5]

Status: Recruiting

A Study of GQ1010 in Subjects With Advanced Solid Tumors

This is an open-label, phase I/II study to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of GQ1010 and preliminary anti-tumor efficacy in advanced malignant solid tumor subjects

Participants needed: 260
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: GeneQuantum Healthcare (Suzhou) Co., Ltd.Updated: Feb 10, 2025Locations: 5
Eligibility criteria

Male or female, ≥18 years old. [+30]

Is a lactating mother or pregnant as confirmed by pregnancy tests; [+25]